番茄社区

Experts at AAD discuss the efficacy and safety of the PDE4 inhibitor in a roundtable discussion

Experts at AAD discuss the efficacy and safety of risankizumab in a roundtable discussion

Experts at AAD discuss the results of the phase IIb study in a roundtable discussion

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD